Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The percentages of CC, CT and TT genotypes at 69 position of ABCA1 gene were 31.63%, 58.16% and 10.21% in control as well as 22.54%, 69.60% and 7.86% in diabetes group respectively.
|
30529097 |
2019 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
There was no association of ABCA1 C69T gene polymorphisms with the risk of diabetes.
|
31010439 |
2019 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Serum capacity to induce ABCA1-mediated cholesterol efflux was impaired in the diabetic group (p < 0.01) and cholesterol efflux correlated with pre-β1 HDL (Pearson's r = 0.38, p < 0.01), and this association remained significantly even after controlling for age, gender, body mass index, diabetes status, smoking, apoA1, triglyceride and LDL.
|
28595104 |
2017 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
In the present study, the effects of metabolites of diabetes and ischemia were observed on PBMNC ABCA1 protein and thus on HDL-C in AMI patients.
|
24796288 |
2015 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
ABCA1 was decreased in all the risk populations except diabetes and male.
|
22614118 |
2012 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Larger studies will help us to understand the relationship between ABCA1 C69T genotype and lipid parameters in diabetes mellitus.
|
22384526 |
2012 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Recently, it has been reported that ABCA1 is expressed in pancreatic beta cells and mice with specific inactivation of ABCA1 in beta cells showed markedly impaired insulin secretion, suggesting that ABCA1 deficiency may be involved in diabetes.
|
19556721 |
2009 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
The ABCA1 pathway has therefore become a promising new therapeutic target for treating cardiovascular disease and diabetes.
|
19344785 |
2009 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Evaluation of genotype distributions by the Chi-square test and subsequent multivariable logistic regression analysis with adjustment for age, sex, body mass index, smoking status, and the prevalence of diabetes mellitus and hypercholesterolemia revealed that the -14C-->T polymorphism of ABCA1, the C-->G (Ser2229Cys) polymorphism of ROS1, the C-->T (Asn591Asn) polymorphism of LDLR, the 13989A-->G (Ile118Val) polymorphism of CYP3A4, the C-->G and A-->C polymorphisms of ADIPOR1, and the -519A-->G polymorphism of MMP1 were significantly (P<0.05) associated with the prevalence of hypertension.
|
18097620 |
2008 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
LHGDN |
R1615P: a novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus.
|
16055210 |
2006 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Metabolites elevated in individuals with the metabolic syndrome and diabetes destabilize ABCA1 protein and decrease cholesterol export from macrophages.
|
16183915 |
2005 |